StemCell Therapy

Years ago, I worked with an editor who
used to advise his lagging scribes to put their noses in their
typewriters and peck.

CIRM staffers blogging the World Stem Cell Summit covered UC Davis researcher Paul Knoepfler discussing patient advocacy and its role in funding stem cell research.

The CIRM writers are doing double-duty
in at least one case. Geoff Lomax, the agency's senior officer for
its standards group, is additionally speaking on a panel at the session. A
handful of other CIRM officials are also appearing at the conference,
which ends tomorrow.

• “Claims of miracle cures for
  diseases
• “Single treatments or cells that
  can treat any type of disease
• “Lack of objective information,
  evidence (such as published medical reports) that a treatment is
  effective
• “Treatment by a doctor who is
  not trained or certified to treat the specific disease
• “No system exists to collect
  information and follow up with patients”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/usBXfuFwqy4/extra-extra-cirm-staffers-blog-world.html

This entry was posted on December 9, 2012 at 7:59 am and is filed under Stem Cell Therapy, Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |